{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:46:01Z","timestamp":1789609561496,"version":"build-2803163510"},"reference-count":76,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>During the coronavirus disease 2019 (COVID-19) pandemic, several studies highlighted a worse prognosis for patients with alterations in liver function tests, especially those with pre-existing liver diseases. However, further studies are needed to define the long-term impact of the COVID-19 pandemic on liver diseases. Long COVID-19 encompasses a wide range of signs and symptoms, including exacerbations of pre-existing chronic conditions or new onset conditions developed after the COVID-19 acute phase. Therefore, the long-term effects of COVID-19 extensively include hepatic manifestations. The co-expression of angiotensin-converting receptor 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2) has been demonstrated also in enterocytes, cholangiocytes, and hepatocytes. Studies on the post-COVID-19 sequelae have shown the presence of steatosis and necroinflammation in the liver, concomitantly with an alteration of inflammation, cytolysis and cholestasis indices. Some studies also demonstrated an increased risk for hepatobiliary pathologies, including secondary biliary cholangitis and worsening of the severity of metabolic-associated fatty liver disease (MASLD). Based on these premises, this review aims to provide an overview of the pathophysiological mechanisms contributing to COVID-19-related liver and hepatobiliary damage; explore its implications for liver inflammation and fibrosis, with a particular focus on MASLD and metabolic dysfunction-associated steatohepatitis (MASH); and analyze the short- and long-term COVID-19 sequelae. A literature search was conducted using the PubMed database for relevant studies published in English.<\/jats:p>","DOI":"10.3390\/life15030403","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T13:31:31Z","timestamp":1741095091000},"page":"403","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Post-COVID-19 Pandemic Sequelae in Liver Diseases"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9146-9968","authenticated-orcid":false,"given":"Cristina","family":"Stasi","sequence":"first","affiliation":[{"name":"Department of Life Science, Health and Health Professions, Link Campus University, 00165 Roma, Italy"},{"name":"Epidemiology Unit, Regional Health Agency of Tuscany, 50141 Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e34320","DOI":"10.1097\/MD.0000000000034320","article-title":"Meta-analysis of liver injury in patients with COVID-19","volume":"102","author":"Li","year":"2023","journal-title":"Medicine"},{"key":"ref_2","unstructured":"World Health Organization (2022). Europe. Post COVID-19 Condition (Long COVID), World Health Organization. Available online: https:\/\/www.who.int\/europe\/news-room\/fact-sheets\/item\/post-covid-19-condition."},{"key":"ref_3","unstructured":"NICE (2024). NICE Guideline [NG188]. COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19, NICE. Available online: https:\/\/www.nice.org.uk\/guidance\/ng188."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1056\/NEJMsb2408466","article-title":"Long COVID Defined","volume":"391","author":"Ely","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"de Lima, I.C., de Menezes, D.C., Uesugi, J.H.E., Bichara, C.N.C., da Costa Vasconcelos, P.F., Quaresma, J.A.S., and Falc\u00e3o, L.F.M. (2023). Liver Function in Patients with Long-Term Coronavirus Disease 2019 of up to 20 Months: A Cross-Sectional Study. Int. J. Environ. Res. Public Health, 20.","DOI":"10.3390\/ijerph20075281"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e2022003","DOI":"10.4084\/MJHID.2022.003","article-title":"Mechanism of SARS-CoV-2 Invasion into the Liver and Hepatic Injury in Patients with COVID-19","volume":"14","author":"Zhang","year":"2022","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jhep.2020.05.030","article-title":"Single cell RNA sequencing analysis did not predict hepatocyte infection by SARS-CoV-2","volume":"73","author":"Verhulst","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jhep.2020.09.027","article-title":"Obese patients with NASH have increased hepatic expression of SARS-CoV-2 critical entry points","volume":"74","author":"Fondevila","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Eskridge, W., Cryer, D.R., Schattenberg, J.M., Gastaldelli, A., Malhi, H., Allen, A.M., Noureddin, M., and Sanyal, A.J. (2023). Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: The Patient and Physician Perspective. J. Clin. Med., 12.","DOI":"10.3390\/jcm12196216"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): A systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"ref_11","unstructured":"European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), and European Association for the Study of Obesity (EASO) (2024). EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J. Hepatol., 81, 492\u2013542."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Nour, T.Y., and Altinta\u015f, K.H. (2023). Effect of the COVID-19 pandemic on obesity and it is risk factors: A systematic review. BMC Public Health, 23.","DOI":"10.1186\/s12889-023-15833-2"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"5556354","DOI":"10.1155\/2021\/5556354","article-title":"NAFLD and Infection, a Nuanced Relationship","volume":"2021","author":"Adenote","year":"2021","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1210\/clinem\/dgac321","article-title":"Global Prevalence and Clinical Characteristics of Metabolic-associated Fatty Liver Disease: A Meta-Analysis and Systematic Review of 10 739 607 Individuals","volume":"107","author":"Chan","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e0629","DOI":"10.1097\/HC9.0000000000000629","article-title":"Increased MASH-associated liver cancer in younger demographics","volume":"9","author":"Danpanichkul","year":"2025","journal-title":"Hepatol. Commun."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Kim, D., Danpanichkul, P., Wijarnpreecha, K., Cholankeril, G., Loomba, R., and Ahmed, A. (2024). Current Burden of Steatotic Liver Disease and Fibrosis among Adults in the United States, 2017\u20132023. Clin. Mol. Hepatol.","DOI":"10.3350\/cmh.2024.0987"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.3748\/wjg.v29.i12.1838","article-title":"Autoimmune liver diseases and SARS-CoV-2","volume":"29","author":"Sgamato","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.dld.2020.07.029","article-title":"Cost of illness of Primary Biliary Cholangitis\u2014A population-based study","volume":"53","author":"Gerussi","year":"2021","journal-title":"Dig. Liver Dis."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver (2017). EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. J. Hepatol., 67, 145\u2013172.","DOI":"10.1016\/j.jhep.2017.03.022"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2147\/JHC.S347959","article-title":"Perspectives on the Underlying Etiology of HCC and Its Effects on Treatment Outcomes","volume":"10","author":"Ito","year":"2023","journal-title":"J. Hepatocell. Carcinoma"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1016\/j.cgh.2022.05.045","article-title":"Trends in Etiology-based Mortality From Chronic Liver Disease Before and During COVID-19 Pandemic in the United States","volume":"20","author":"Kim","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/jvh.13980","article-title":"Impact of COVID-19 pandemic on hepatocellular carcinoma surveillance in British Columbia, Canada: An interrupted time series study","volume":"31","author":"Makuza","year":"2024","journal-title":"J. Viral Hepat."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Silvestri, C., Stasi, C., Profili, F., Bartolacci, S., Sessa, E., Tacconi, D., Villari, L., Carrozzi, L., Dotta, F., and Bargagli, E. (2024). Retrospective Study on the Features and Outcomes of a Tuscany COVID-19 Hospitalized Patients Cohort: Preliminary Results. J. Clin. Med., 13.","DOI":"10.3390\/jcm13164626"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Romano, C., Cozzolino, D., Nevola, R., Abitabile, M., Carusone, C., Cinone, F., Cuomo, G., Nappo, F., Sellitto, A., and Umano, G.R. (2023). Liver Involvement during SARS-CoV-2 Infection Is Associated with a Worse Respiratory Outcome in COVID-19 Patients. Viruses, 15.","DOI":"10.3390\/v15091904"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1097\/MS9.0000000000000645","article-title":"Liver injury at admission and outcomes in patients with COVID-19 disease: A prospective cohort study","volume":"85","author":"Poudel","year":"2023","journal-title":"Ann. Med. Surg."},{"key":"ref_26","first-page":"1","article-title":"SARS-CoV-2 Receptors and Their Involvement in Cell Infection","volume":"17","author":"Avdonin","year":"2023","journal-title":"Biochem. (Mosc.) Suppl. Ser. A Membr. Cell Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3748\/wjg.v28.i3.275","article-title":"Endothelial cells and blood vessels are major targets for COVID-19-induced tissue injury and spreading to various organs","volume":"28","author":"Tarnawski","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.jhep.2024.06.014","article-title":"Procoagulant phenotype of virus-infected pericytes is associated with portal thrombosis and intrapulmonary vascular dilations in fatal COVID-19","volume":"81","author":"Cadamuro","year":"2024","journal-title":"J. Hepatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1007\/s12072-023-10521-0","article-title":"Hepatobiliary long-term consequences of COVID-19: Dramatically increased rate of secondary sclerosing cholangitis in critically ill COVID-19 patients","volume":"17","author":"Leonhardt","year":"2023","journal-title":"Hepatol. Int."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Chen, T.H., Hsu, M.T., Lee, M.Y., and Chou, C.K. (2022). Gastrointestinal Involvement in SARS-CoV-2 Infection. Viruses, 14.","DOI":"10.3390\/v14061188"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"100936","DOI":"10.1016\/j.jhepr.2023.100936","article-title":"SARS-CoV-2 receptor ACE2 is upregulated by fatty acids in human MASH","volume":"6","author":"Cano","year":"2023","journal-title":"JHEP Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1042\/CS20201268","article-title":"ACE2: From protection of liver disease to propagation of COVID-19","volume":"134","author":"Warner","year":"2020","journal-title":"Clin. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"de Miranda, A.S., and Sim\u00f5es e Silva, A.C. (2019). Liver. Angiotensin-(1-7), Springer.","DOI":"10.1007\/978-3-030-22696-1_12"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.livres.2023.07.001","article-title":"COVID-19 associated liver injury: An updated review on the mechanisms and management of risk groups","volume":"5","author":"Shi","year":"2023","journal-title":"Liver Res."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Mercado-G\u00f3mez, M., Prieto-Fern\u00e1ndez, E., Goikoetxea-Usandizaga, N., Vila-Vecilla, L., Azkargorta, M., Bravo, M., Serrano-Maci\u00e1, M., Egia-Mendikute, L., Rodr\u00edguez-Agudo, R., and Lachiondo-Ortega, S. (2022). The spike of SARS-CoV-2 promotes metabolic rewiring in hepatocytes. Commun. Biol., 5.","DOI":"10.1038\/s42003-022-03789-9"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e70156","DOI":"10.1002\/jmv.70156","article-title":"SARS-CoV-2 Productively Infects Human Hepatocytes and Induces Cell Death","volume":"97","author":"Ko","year":"2025","journal-title":"J. Med. Virol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e12977","DOI":"10.1111\/sji.12977","article-title":"COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel","volume":"93","author":"Napodano","year":"2021","journal-title":"Scand. J. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Zeuzem, A., Kumar, S.D., Oltmanns, C., Witte, M., Mischke, J., Drick, N., Fuge, J., Pink, I., Tauwaldt, J., and Debarry, J. (2024). Different dynamics of soluble inflammatory mediators after clearance of respiratory SARS-CoV-2 versus blood-borne hepatitis C virus infections. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-79909-8"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.3748\/wjg.v30.i22.2866","article-title":"Histopathological impact of SARS-CoV-2 on the liver: Cellular damage and long-term complications","volume":"30","year":"2024","journal-title":"World J. Gastroenterol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.jhep.2020.05.002","article-title":"SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19","volume":"73","author":"Wang","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Lebbe, A., Aboulwafa, A., Bayraktar, N., Mushannen, B., Ayoub, S., Sarker, S., Abdalla, M.N., Mohammed, I., Mushannen, M., and Yagan, L. (2024). New Onset of Acute and Chronic Hepatic Diseases Post-COVID-19 Infection: A Systematic Review. Biomedicines, 12.","DOI":"10.3390\/biomedicines12092065"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"101645","DOI":"10.1016\/j.isci.2020.101645","article-title":"SARS-CoV-2 Infection Dysregulates the Metabolomic and Lipidomic Profiles of Serum","volume":"23","author":"Bruzzone","year":"2020","journal-title":"iScience"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1113\/EP091590","article-title":"DYNamic Assessment of Multi-Organ level dysfunction in patients recovering from COVID-19: DYNAMO COVID-19","volume":"109","author":"Gupta","year":"2024","journal-title":"Exp. Physiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/ajum.12390","article-title":"Assessment of the liver with two-dimensional shear wave elastography following COVID-19 infection: A pilot study","volume":"27","author":"Lau","year":"2024","journal-title":"Australas. J. Ultrasound Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3748\/wjg.v23.i2.191","article-title":"Evolving strategies for liver fibrosis staging: Non-invasive assessment","volume":"23","author":"Stasi","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"\u017bmudka, K., Jaroszewicz, J., Zar\u0119bska-Michaluk, D., Rogalska, M., Czupryna, P., Rorat, M., Kozielewicz, D., Maciukaj\u0107, J., Kiciak, S., and Kr\u0119pa, M. (2024). Association between Liver Damage and Disease Progression Markers with Mortality Risk and Mechanical Ventilation in Hospitalized COVID-19 Patients: A Nationwide Retrospective SARSTer Study. Viruses, 16.","DOI":"10.3390\/v16101530"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e70004","DOI":"10.1002\/jgh3.70004","article-title":"Comparison of liver fibrosis scores and fatty liver on computed tomography as risk factors for severity of COVID-19","volume":"8","author":"Kamiya","year":"2024","journal-title":"JGH Open"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Galiero, R., Loffredo, G., Simeon, V., Caturano, A., Vetrano, E., Medicamento, G., Alfano, M., Beccia, D., Brin, C., and Colantuoni, S. (2024). Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy. PLoS ONE, 19.","DOI":"10.1371\/journal.pone.0296495"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/liv.15815","article-title":"NAFLD and NASH are obesity-independent risk factors in COVID-19: Matched real-world results from the large PINC AI\u2122 Healthcare Database","volume":"44","author":"Brozat","year":"2024","journal-title":"Liver Int."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e16582","DOI":"10.7717\/peerj.16582","article-title":"The mortality of hospitalized patients with COVID-19 and non-cirrhotic chronic liver disease: A retrospective multi-center study","volume":"11","author":"Wu","year":"2023","journal-title":"PeerJ"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e213","DOI":"10.1017\/cts.2023.594","article-title":"Fibrosis-4 (FIB-4) index as a predictor for mechanical ventilation and 30-day mortality across COVID-19 variants","volume":"7","author":"Parajuli","year":"2023","journal-title":"J. Clin. Transl. Sci."},{"key":"ref_52","first-page":"781","article-title":"The Association between the Fibrosis-4 Index and COVID-19: A Systematic Review and Meta-Analysis","volume":"52","author":"Ao","year":"2022","journal-title":"Ann. Clin. Lab. Sci."},{"key":"ref_53","first-page":"465","article-title":"FIB-4 score as a predictor of COVID-19-related severity in hospitalized patients","volume":"116","year":"2024","journal-title":"Rev. Esp. Enferm. Dig."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Kolesova, O., Vanaga, I., Laivacuma, S., Derovs, A., Kolesovs, A., Radzina, M., Platkajis, A., Eglite, J., Hagina, E., and Arutjunana, S. (2021). Intriguing findings of liver fibrosis following COVID-19. BMC Gastroenterol., 21.","DOI":"10.1186\/s12876-021-01939-7"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.gastha.2023.01.020","article-title":"Differential Effects of COVID-19 Hospitalization on the Trajectory of Liver Disease Progression","volume":"2","author":"Mulligan","year":"2023","journal-title":"Gastro Hep Adv."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.dld.2018.12.005","article-title":"Comparison and correlation of fibrosis stage assessment by collagen proportionate area (CPA) and the ELF panel in patients with chronic liver disease","volume":"51","author":"Stasi","year":"2019","journal-title":"Dig. Liver Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"107394","DOI":"10.1016\/j.rmed.2023.107394","article-title":"Utility of the Enhanced Liver Fibrosis score as a blood biomarker of pulmonary fibrosis secondary to SARS-CoV-2 pneumonia","volume":"218","author":"Aljama","year":"2023","journal-title":"Respir. Med."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Bota, A.V., Bratosin, F., Bandi, S.S.S., Bogdan, I., Razvan, D.V., Toma, A.O., Indries, M.F., Csep, A.N., Cotoraci, C., and Prodan, M. (2024). A Comparative Analysis of Liver Injury Markers in Post-COVID Syndrome among Elderly Patients: A Prospective Study. J. Clin. Med., 13.","DOI":"10.3390\/jcm13041149"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Liu, Z., Hu, B., Zeng, T., You, C., Li, N., Liu, Y., Zhang, J., Liu, C., Jin, P., and Feng, X. (2025). A comparative cohort study of post-COVID-19 conditions based on physical examination records in China. EBioMedicine, 112.","DOI":"10.1016\/j.ebiom.2024.105549"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"\u0130nal, N., Kurumanast\u0131rl\u0131, B., Ta\u015fk\u0131no\u011flu, T., Duran, A.\u00c7., Togay, A., Sar\u0131g\u00fczel, F.M., Ka\u015fifo\u011flu, N., Soylu, M., Do\u011fan, Y., and Us, E. (2024). Retrospective evaluation of \u201cRods and Rings\u201d pattern detected in the anti-nuclear antibody (ANA) indirect immunofluorescence (IIF) test. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1359030"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e2523","DOI":"10.1002\/rmv.2523","article-title":"Risk of kidney and liver diseases after COVID-19 infection: A systematic review and meta-analysis","volume":"34","author":"Pan","year":"2024","journal-title":"Rev. Med. Virol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"296","DOI":"10.5662\/wjm.v13.i4.296","article-title":"Post-COVID-19 cholangiopathy: Systematic review","volume":"13","author":"Rasheed","year":"2023","journal-title":"World J. Methodol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"943","DOI":"10.3350\/cmh.2024.0203","article-title":"Long-term gastrointestinal and hepatobiliary outcomes of COVID-19: A multinational population-based cohort study from South Korea, Japan, and the UK","volume":"30","author":"Lee","year":"2024","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1002\/hep.32582","article-title":"Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID-19 in patients with chronic liver disease","volume":"76","author":"Hartl","year":"2022","journal-title":"Hepatology"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Stasi, C., Meoni, B., Voller, F., and Silvestri, C. (2022). SARS-CoV-2 Vaccination and the Bridge between First and Fourth Dose: Where Are We?. Vaccines, 10.","DOI":"10.3390\/vaccines10030444"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.jhep.2021.01.032","article-title":"EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients","volume":"74","author":"Cornberg","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jhep.2023.10.009","article-title":"Immune responses and clinical outcomes after COVID-19 vaccination in patients with liver disease and liver transplant recipients","volume":"80","author":"Murray","year":"2024","journal-title":"J. Hepatol."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Airola, C., Andaloro, S., Gasbarrini, A., and Ponziani, F.R. (2024). Vaccine Responses in Patients with Liver Cirrhosis: From the Immune System to the Gut Microbiota. Vaccines, 12.","DOI":"10.3390\/vaccines12040349"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Cui, J., Wang, L., Ghavamian, A., Li, X., Wang, G., Wang, T., Huang, M., Ru, Q., and Zhao, X. (2024). Long-term antibody response after the third dose of inactivated SARS-CoV-2 vaccine in MASLD patients. BMC Gastroenterol., 24.","DOI":"10.1186\/s12876-024-03402-9"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"173644","DOI":"10.1016\/j.ejphar.2020.173644","article-title":"Treatment for COVID-19: An overview","volume":"889","author":"Stasi","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"100113","DOI":"10.1016\/j.jhepr.2020.100113","article-title":"Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper","volume":"2","author":"Boettler","year":"2020","journal-title":"JHEP Rep."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"100169","DOI":"10.1016\/j.jhepr.2020.100169","article-title":"Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic","volume":"2","author":"Boettler","year":"2020","journal-title":"JHEP Rep."},{"key":"ref_73","unstructured":"Long COVID-19 Syndrome Lifestyle Intervention Study (2024, April 29). ClinicalTrials.gov ID NCT05836402, Available online: https:\/\/clinicaltrials.gov\/study\/NCT05836402?cond=Long%20COVID-19%20Syndrome&term=Liver%20Diseases&limit=25&page=1&rank=1."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1473-3099(23)00685-0","article-title":"A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong (RECOVERY): A randomised, double-blind, placebo-controlled trial","volume":"24","author":"Lau","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"100907","DOI":"10.1016\/j.cpcardiol.2021.100907","article-title":"Alterations of Lipid Profile in COVID-19: A Narrative Review","volume":"47","author":"Rezaei","year":"2022","journal-title":"Curr. Probl. Cardiol."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Grootemaat, A.E., van der Niet, S., Scholl, E.R., Roos, E., Schurink, B., Bugiani, M., Miller, S.E., Larsen, P., Pankras, J., and Reits, E.A. (2022). Lipid and Nucleocapsid N-Protein Accumulation in COVID-19 Patient Lung and Infected Cells. Microbiol. Spectr., 10.","DOI":"10.1128\/spectrum.01271-21"}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/15\/3\/403\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:47:12Z","timestamp":1760028432000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/15\/3\/403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,4]]},"references-count":76,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["life15030403"],"URL":"https:\/\/doi.org\/10.3390\/life15030403","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,4]]}}}